Suchergebnisse - "Wang, Xinghua"

PubPharm (6)

1

Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway

enthalten in: Cardiovascular drugs and therapy | 2021

von Zhao, Z. | Li, R. | Wang, X. | +5

2

Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway

enthalten in: Cardiovascular drugs and therapy | 2020

von Zhao, Z. | Li, R. | Wang, X. | +5

3

Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway

enthalten in: Cardiovascular drugs and therapy | 2020

von Zhao, Z. | Li, R. | Wang, X. | +5

4

Attenuation of atrial remodeling by aliskiren via affecting oxidative stress, inflammation and PI3K/Akt signaling pathway

enthalten in: Cardiovascular drugs and therapy | 2020

von Zhao, Z. | Li, R. | Wang, X. | +5

5

Suppression of experimental atrial fibrillation in a canine model of rapid atrial pacing by the phosphodiesterase 3 inhibitor cilostazol

enthalten in: Journal of electrocardiology | 2020

von Zhao, Z. | Li, R. | Wang, X. | +5

6

Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits

enthalten in: Cardiovascular therapeutics | 2017

von Liu, C. | Liu, R. | Fu, H. | +7

1
[1]